The Technology Co.,Ltd.

KOSDAQ:A043090 Stock Report

Market Cap: ₩19.4b

TechnologyLtd Past Earnings Performance

Past criteria checks 0/6

TechnologyLtd's earnings have been declining at an average annual rate of -29.6%, while the Life Sciences industry saw earnings growing at 17.2% annually. Revenues have been growing at an average rate of 24.5% per year.

Key information

-29.6%

Earnings growth rate

-9.6%

EPS growth rate

Life Sciences Industry Growth53.7%
Revenue growth rate24.5%
Return on equity-50.8%
Net Margin-139.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Investors Give The Technology Co.,Ltd. (KOSDAQ:043090) Shares A 36% Hiding

Oct 30
Investors Give The Technology Co.,Ltd. (KOSDAQ:043090) Shares A 36% Hiding

Is TechnologyLtd (KOSDAQ:043090) A Risky Investment?

Oct 21
Is TechnologyLtd (KOSDAQ:043090) A Risky Investment?

Slammed 27% The Technology Co.,Ltd. (KOSDAQ:043090) Screens Well Here But There Might Be A Catch

Jul 24
Slammed 27% The Technology Co.,Ltd. (KOSDAQ:043090) Screens Well Here But There Might Be A Catch

Is TechnologyLtd (KOSDAQ:043090) Using Too Much Debt?

Jul 22
Is TechnologyLtd (KOSDAQ:043090) Using Too Much Debt?

Potential Upside For The Technology Co.,Ltd. (KOSDAQ:043090) Not Without Risk

May 22
Potential Upside For The Technology Co.,Ltd. (KOSDAQ:043090) Not Without Risk

Would Exergy21 (KOSDAQ:043090) Be Better Off With Less Debt?

Feb 28
Would Exergy21 (KOSDAQ:043090) Be Better Off With Less Debt?

Revenue & Expenses Breakdown

How TechnologyLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A043090 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2413,692-19,08811,6770
30 Jun 2415,746-17,17612,4750
31 Mar 2417,408-24,97919,6280
31 Dec 2315,895-27,11119,4090
30 Sep 2311,183-22,16415,6370
30 Jun 236,739-19,82513,5470
31 Mar 233,365-10,7325,6720
31 Dec 223,897-3,3415,1010
30 Sep 229,9502,3665,1980
31 Dec 218,848-2,2395,2340
30 Sep 212,865-9,5823,9090
30 Jun 213,415-7,4083,7530
31 Mar 213,780-7,4493,6090
31 Dec 205,207-6,7303,6250
30 Sep 205,754-6,4454,9064
30 Jun 206,017-8,5304,8744
31 Mar 207,082-7,3024,95134
31 Dec 197,378-8,2105,359152
31 Dec 1420,672-1,6165,398357
30 Sep 1420,7592233,427335
30 Jun 1420,298913,357348
31 Mar 1420,6985083,044349
31 Dec 1321,4331652,724381

Quality Earnings: A043090 is currently unprofitable.

Growing Profit Margin: A043090 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A043090 is unprofitable, and losses have increased over the past 5 years at a rate of 29.6% per year.

Accelerating Growth: Unable to compare A043090's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A043090 is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (39.6%).


Return on Equity

High ROE: A043090 has a negative Return on Equity (-50.81%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 20:46
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

The Technology Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution